OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics®, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its mammalian cell culture capabilities with the addition of cell line development services, strengthening its ability to provide a seamless path from DNA to IND submission for its customers. The launch of new cell line development services reflects Cytovance’s continued investment in innovati